PMID- 28125174
OWN - NLM
STAT- MEDLINE
DCOM- 20170607
LR  - 20220318
IS  - 1555-2101 (Electronic)
IS  - 0160-6689 (Linking)
VI  - 78 Suppl 1
DP  - 2017
TI  - Pharmacologic Treatments for Binge-Eating Disorder.
PG  - 14-19
LID - 10.4088/JCP.sh16003su1c.03 [doi]
AB  - Binge-eating disorder (BED) is the most common eating disorder and is associated 
      with poor physical and mental health outcomes. Psychological and behavioral 
      interventions have been a mainstay of treatment for BED, but as understanding of 
      this disorder has grown, pharmacologic agents have become promising treatment 
      options for some patients. At this time, only one drug-the stimulant prodrug 
      lisdexamfetamine-is approved for the treatment of BED. Numerous classes of 
      medications including antidepressants, anticonvulsants, and antiobesity drugs 
      have been explored as off-label treatments for BED with variable success. 
      Although not all patients with BED may be suitable candidates for 
      pharmacotherapy, all patients should be considered for and educated about 
      pharmacologic treatment options.
CI  - (c) Copyright 2017 Physicians Postgraduate Press, Inc.
FAU - McElroy, Susan L
AU  - McElroy SL
AD  - Lindner Center of HOPE, 4075 Old Western Rd, Mason, OH 45040. 
      susan.mcelroy@lindnercenter.org.
AD  - Lindner Center of HOPE, Mason, and College of Medicine, University of Cincinnati, 
      Ohio, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Clin Psychiatry
JT  - The Journal of clinical psychiatry
JID - 7801243
RN  - 0 (Psychotropic Drugs)
RN  - SJT761GEGS (Lisdexamfetamine Dimesylate)
SB  - IM
MH  - Adult
MH  - Binge-Eating Disorder/diagnosis/*drug therapy/psychology
MH  - Cognitive Behavioral Therapy
MH  - Combined Modality Therapy
MH  - Humans
MH  - Lisdexamfetamine Dimesylate/*therapeutic use
MH  - Obesity/diagnosis/drug therapy/psychology
MH  - Off-Label Use
MH  - Patient Education as Topic
MH  - Psychotropic Drugs/*therapeutic use
MH  - Randomized Controlled Trials as Topic
MH  - Treatment Outcome
EDAT- 2017/01/27 06:00
MHDA- 2017/06/08 06:00
CRDT- 2017/01/27 06:00
PHST- 2017/01/27 06:00 [entrez]
PHST- 2017/01/27 06:00 [pubmed]
PHST- 2017/06/08 06:00 [medline]
AID - 10.4088/JCP.sh16003su1c.03 [doi]
PST - ppublish
SO  - J Clin Psychiatry. 2017;78 Suppl 1:14-19. doi: 10.4088/JCP.sh16003su1c.03.